Aspirin for the primary prevention of cardiovascular events: considerations regarding the risk/benefit.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 20424413.
- Also identified by DOI 10.3810/psm.2010.04.1773.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This update of the 2002 US Preventive Services Task Force (USPSTF) recommendation on the benefits and harms of aspirin for the primary prevention of cardiovascular disease (including myocardial infarction and stroke) suggests that the benefits of aspirin are likely to outweigh the risks in middle-aged and older men and women at increased risk for cardiovascular events. ORIGINAL ARTICLE: U.S. Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;150(6):396-404.